Abivax S.A. (ABVX) Free Cash Flow (2024 - 2026)

Abivax (ABVX) posted quarterly Free Cash Flow of $63220.3 for Q1 2026, up 100.18% year-over-year from $31581.6 in Q1 2025, and up 100.23% on a QoQ basis from -$27.2 million in Q4 2025.

Abivax S.A. (ABVX) Free Cash Flow (2024 - 2026) Analysis & Trends

Abivax (ABVX) has reported Free Cash Flow for 3 consecutive years, with $63220.3 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Free Cash Flow rose 100.18% year-over-year to $63220.3; the TTM figure through Mar 2026 stood at -$148.2 million (up 9.97% YoY), while the FY2025 annual figure was -$187.7 million, down 13.51% from the prior year.
  • Free Cash Flow came in at $63220.3 for Q1 2026 at Abivax, up from -$27.2 million in the prior quarter.
  • The five-year high for Free Cash Flow was $63220.3 in Q1 2026, with the low at -$83.3 million in Q3 2025.
  • Average Free Cash Flow over 3 years is -$39.0 million, with a median of -$37.7 million recorded in 2025.
  • Across the five-year window, Free Cash Flow slumped 116.38% in 2025 and jumped 100.18% in 2026, its largest moves.
  • Year by year, Free Cash Flow stood at -$37.1 million in 2024, then climbed by 26.62% to -$27.2 million in 2025, then soared by 100.23% to $63220.3 in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered $63220.3, -$27.2 million, and -$83.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 63,220.27
Mar 31, 2026 63,220.27
Dec 31, 2025 -27.23 Mn
Dec 31, 2025 -27.23 Mn
Sep 30, 2025 -83.34 Mn
Sep 30, 2025 -83.34 Mn
Jun 30, 2025 -37.72 Mn
Jun 30, 2025 -37.72 Mn
Mar 31, 2025 -34.96 Mn
Mar 31, 2025 -34.96 Mn
Dec 31, 2024 -37.11 Mn
Dec 31, 2024 -37.11 Mn
Sep 30, 2024 -38.52 Mn
Sep 30, 2024 -38.52 Mn
Jun 30, 2024 -54.06 Mn
Jun 30, 2024 -54.06 Mn
Mar 31, 2024 -37.74 Mn
Mar 31, 2024 -37.74 Mn